CARLSBAD, Calif., April 27, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will webcast a management presentation to investors as part of the Morgan Stanley West Coast Medtech and Life Science Tools Bus Trip which is being held at the company's headquarters in Carlsbad on Monday, May 16 at 1:00 PM PT. David Hoffmeister, Life Technologies' Senior Vice President and Chief Financial Officer, will present on behalf of the company.
The webcast may be accessed from the Life Technologies' investor relations website at ir.lifetechnologies.com/events.cfm. The webcast will be available at for three weeks following the presentation.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.
|SOURCE Life Technologies Corporation|
Copyright©2010 PR Newswire.
All rights reserved